Aflac (NYSE:AFL) Issues Quarterly Earnings Results, Misses Expectations By $0.01 EPS

Aflac (NYSE:AFL) posted its earnings results on Thursday. The financial services provider reported $1.75 EPS for the quarter, missing the consensus estimate of $1.76 by ($0.01), FiscalAI reports. The business had revenue of $4.22 billion during the quarter, compared to analyst estimates of $4.11 billion. Aflac had a net margin of 26.91% and a return on equity of 13.37%. The firm’s revenue was down 1.0% compared to the same quarter last year. During the same quarter in the prior year, the business earned $1.78 earnings per share.

Aflac Price Performance

Shares of Aflac stock traded down $2.02 during trading on Friday, hitting $124.64. The stock had a trading volume of 2,452,894 shares, compared to its average volume of 1,990,528. The business has a fifty day moving average of $120.72 and a two-hundred day moving average of $115.37. Aflac has a fifty-two week low of $101.49 and a fifty-two week high of $130.22. The firm has a market cap of $63.44 billion, a P/E ratio of 13.36, a PEG ratio of 1.95 and a beta of 0.60. The company has a debt-to-equity ratio of 0.26, a current ratio of 0.11 and a quick ratio of 0.11.

Aflac Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, September 1st. Stockholders of record on Wednesday, August 19th will be issued a $0.61 dividend. The ex-dividend date is Wednesday, August 19th. This represents a $2.44 annualized dividend and a dividend yield of 2.0%. Aflac’s dividend payout ratio is 27.70%.

Insider Transactions at Aflac

In other Aflac news, major shareholder Post Holdings Co. Ltd. Japan sold 63,000 shares of the business’s stock in a transaction dated Friday, June 5th. The shares were sold at an average price of $118.12, for a total value of $7,441,560.00. Following the sale, the insider directly owned 51,169,435 shares in the company, valued at approximately $6,044,133,662.20. The trade was a 0.12% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold 744,073 shares of company stock worth $87,022,570 over the last quarter. 0.80% of the stock is owned by insiders.

Hedge Funds Weigh In On Aflac

Hedge funds have recently made changes to their positions in the business. Quarry LP bought a new stake in Aflac during the fourth quarter worth approximately $25,000. Darwin Wealth Management LLC bought a new position in shares of Aflac in the second quarter valued at $33,000. Birchwood Financial Partners Inc. acquired a new stake in shares of Aflac during the 4th quarter valued at $36,000. Ankerstar Wealth LLC acquired a new stake in shares of Aflac during the 4th quarter valued at $48,000. Finally, Headlands Technologies LLC acquired a new stake in shares of Aflac during the 2nd quarter valued at $67,000. Institutional investors and hedge funds own 67.44% of the company’s stock.

More Aflac News

Here are the key news stories impacting Aflac this week:

• Positive Sentiment: Aflac declared a quarterly dividend of $0.61 per share, payable September 1 to shareholders of record on August 19. The dividend represents an annualized payout of approximately $2.44 per share and a yield near 2.0%, supporting the stock’s income appeal. Aflac Announces Second Quarter 2026 Results and Dividend
• Positive Sentiment: Second-quarter revenue reached $4.22 billion, exceeding the roughly $4.11 billion consensus estimate. Management also highlighted solid U.S. sales, strong policy persistency and ongoing capital returns as signs of underlying business stability. Aflac Misses Q2 EPS Estimates Despite Solid US Sales Growth
• Neutral Sentiment: Aflac’s quarterly earnings call and presentation provided additional details on operating trends, sales momentum and financial performance for investors assessing the company’s outlook. Aflac Q2 2026 Earnings Call Transcript
• Negative Sentiment: Adjusted earnings were $1.75 per share, below analyst estimates ranging from $1.76 to $1.79 and down from $1.78 a year earlier. Lower investment income and unfavorable foreign-exchange effects, including a stronger dollar, weighed on profitability. Aflac Q2 Earnings Lag Estimates
• Negative Sentiment: Revenue declined approximately 1.0% year over year, while the earnings shortfall reinforces concerns about near-term investment income and currency headwinds. These factors likely explain the negative investor reaction despite the revenue beat. Aflac Q2 Earnings Snapshot

Analysts Set New Price Targets

Several research firms have recently issued reports on AFL. UBS Group reissued a “neutral” rating and issued a $124.00 price target (up from $114.00) on shares of Aflac in a research note on Wednesday, July 8th. Mizuho set a $112.00 price objective on shares of Aflac in a research note on Thursday, July 9th. Piper Sandler reaffirmed an “overweight” rating and issued a $130.00 price objective (up from $125.00) on shares of Aflac in a report on Tuesday, May 26th. Wall Street Zen upgraded shares of Aflac from a “sell” rating to a “hold” rating in a research report on Saturday, May 9th. Finally, Jefferies Financial Group reissued a “hold” rating and set a $108.00 target price (up from $100.00) on shares of Aflac in a research note on Friday, July 10th. Two analysts have rated the stock with a Strong Buy rating, two have assigned a Buy rating, seven have issued a Hold rating and two have assigned a Sell rating to the stock. According to MarketBeat.com, Aflac has an average rating of “Hold” and an average price target of $116.25.

About Aflac

Aflac Incorporated (American Family Life Assurance Company of Columbus) is a provider of supplemental insurance products designed to help policyholders manage out-of-pocket health care and living expenses. The company underwrites a range of individual and group policies that typically pay cash benefits directly to insureds when covered events occur, enabling greater financial flexibility for medical treatment, hospital stays, critical illness, and related costs. Aflac’s product mix includes supplemental health insurance, life insurance and other specialty coverages intended to complement primary medical plans.

Founded in the mid-20th century and headquartered in Columbus, Georgia, Aflac distributes its products through a combination of employer-sponsored programs, independent brokers and agents, and direct marketing.